Rxivist logo

Kelch13 and MDR1 Polymorphisms, and Drug Effectiveness at Day 3 after Dihydroartemisinin-Piperaquine Treatment for Plasmodium falciparum Malaria on Bioko Island, Equatorial Guinea: 2014-2017

By Yu-Zhong Zheng, Jiang-Tao Chen, Xue-Yan Liang, Carlos Salas Ehapo, Urbano Monsuy Eyi, Hui-Ying Huang, Wei-Zhong Chen, Li-Yun Lin, Dong-De Xie, Yu-Ling Wang, Guo-Wei Chen, Xiang-Zhi Liu, Guang-Cai Zha, Huan-Tong Mo, Xin-Yao Chen, Jian Li, Ting-Ting Jiang, Min Lin

Posted 05 Apr 2019
bioRxiv DOI: 10.1101/594366

Artemisinin (ART) combination therapies were introduced on malaria endemic Bioko Island in 2004 through Bioko Island Malaria Control Project. Recently, ART-resistant Plasmodium falciparum strain with Kelch13 (K13) propeller M579I mutation originating from Equatorial Guinea was observed as an increased parasite clearance time on day 3 after dihydroartemisinin-Piperaquine (DHA-PIP) treatment (D3 positivity). Here, we surveyed DHA-PIP effectiveness and molecular markers of drug resistance at D3 after DHA-PIP treatment on Bioko Island from 2014 to 2017. Among the 371 uncomplicated P. falciparum patients, 86.3% (320/471) were successfully followed up at D3. 5.9% (19/320) of patients showed D3 positivity. K13 and MDR1 gene were successfully sequenced from 46 patients collected at D0 (baseline population) and 19 D3-positivity patients. Five non-synonymous K13 mutations (H136N; K189N; K248N; K326E; K332N) were found. There was no statistical difference in the frequency of these K13 mutations between baseline population and D3-positivity samples (p>0.05). Additionally, none of the K13 propeller polymorphisms known to be involved in ART-resistance in Asia or Africa were detected. For MDR1 gene, 38.5% (25/65) carried N86Y mutation; 73.8% (48/65) the Y184F mutation. Parasites surviving DHA-PIP at D3 post-treatment were significantly more likely than the baseline population to carry the N86Y (p <0.05). These results suggest that K13 is not the best predictive molecular marker for ART resistance in Africa. More isolates from cases with delayed parasite clearance after DHA-PIP treatment indicated that in vitro and in vivo monitoring for ART derivatives and ACT partner drugs should be regularly performed on Bioko Island, Equatorial Guinea.

Download data

  • Downloaded 238 times
  • Download rankings, all-time:
    • Site-wide: 123,842
    • In epidemiology: 5,201
  • Year to date:
    • Site-wide: 145,207
  • Since beginning of last month:
    • Site-wide: 141,865

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide